Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

SHE:002550 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 17, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	12,273	7,749	7,525	8,012	6,181	5,439
Market Cap Growth	55.84%	2.97%	-6.07%	29.61%	13.64%	-7.21%
Enterprise Value	11,524	7,071	7,054	7,508	5,582	4,818
Last Close Price	9.82	6.09	5.66	5.90	4.45	3.80
PE Ratio	28.90	21.76	41.38	24.77	34.14	-
Forward PE	33.86	20.00	20.00	20.00	20.00	20.00
PS Ratio	8.01	5.08	4.15	3.48	3.30	3.26
PB Ratio	4.69	3.08	3.04	3.29	2.92	2.63
P/TBV Ratio	4.90	3.23	3.23	3.43	3.08	2.78
P/FCF Ratio	49.51	18.27	17.38	-	468.80	21.35
P/OCF Ratio	32.61	15.06	14.11	-	59.69	17.14
EV/Sales Ratio	7.52	4.63	3.89	3.26	2.98	2.89
EV/EBITDA Ratio	26.87	20.39	30.49	26.13	25.17	17.19
EV/EBIT Ratio	31.44	25.06	43.50	33.74	36.63	22.94
EV/FCF Ratio	46.49	16.68	16.29	-	423.36	18.91
Debt / Equity Ratio	0.01	0.01	0.02	0.04	0.04	0.02
Debt / EBITDA Ratio	0.05	0.06	0.24	0.36	0.42	0.15
Debt / FCF Ratio	0.08	0.05	0.13	-	7.10	0.16
Asset Turnover	0.56	0.55	0.65	0.87	0.76	0.62
Inventory Turnover	1.64	1.35	1.84	3.03	2.92	3.13
Quick Ratio	7.01	5.39	4.89	4.00	3.83	4.18
Current Ratio	11.01	7.58	7.90	6.07	5.30	5.35
Return on Equity (ROE)	16.33%	13.35%	7.28%	14.06%	8.91%	-6.71%
Return on Assets (ROA)	8.33%	6.30%	3.64%	5.24%	3.84%	4.87%
Return on Capital (ROIC)	9.13%	6.96%	4.00%	5.86%	4.41%	5.49%
Return on Capital Employed (ROCE)	13.50%	10.80%	6.30%	8.80%	6.90%	9.70%
Earnings Yield	3.51%	4.59%	2.42%	4.04%	2.93%	-2.43%
FCF Yield	2.02%	5.47%	5.75%	-1.78%	0.21%	4.68%
Dividend Yield	1.22%	1.97%	2.12%	2.04%	2.70%	3.16%
Payout Ratio	34.94%	42.56%	87.31%	47.98%	83.67%	-
Buyback Yield / Dilution	1.40%	2.11%	-0.41%	-7.16%	-0.58%	4.01%
Total Shareholder Return	2.61%	4.08%	1.71%	-5.13%	2.11%	7.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.